サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434620

生殖補助医療市場：タイプ別、診断別、エンドユーザー別-2024-2030年の世界予測

Assisted Reproductive Technology Market (ART) by Type (Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer), Diagnosis (Genetic Testing, Hormone Testing, Hysterosalpingography), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
生殖補助医療市場：タイプ別、診断別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生殖補助医療市場規模は2023年に251億2,000万米ドルと推計され、2024年には295億2,000万米ドルに達し、CAGR 17.57%で2030年には780億4,000万米ドルに達すると予測されます。

生殖補助医療の世界市場

主な市場の統計
基準年[2023］ 251億2,000万米ドル
予測年[2024] 295億2,000万米ドル
予測年 [2030] 780億4,000万米ドル
CAGR（%） 17.57%
生殖補助医療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは生殖補助医療市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、生殖補助医療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-生殖補助医療市場の市場規模および予測は？

2-生殖補助医療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-生殖補助医療市場における技術動向と規制の枠組みは？

4-生殖補助医療市場における主要ベンダーの市場シェアは？

5-生殖補助医療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ストレス、公害、肥満による不妊症の増加
      • 新興国全体でヘルスケア費が増加
      • 卵巣がんおよび子宮内膜がんと多嚢胞性卵巣症候群の有病率の増加
    • 抑制要因
      • 手術費が高く、成功率が低い
    • 機会
      • 政府および公的機関による意識向上の取り組み
      • 治療による合併症を軽減するための技術進歩
    • 課題
      • 新興経済諸国における先進インフラの不足
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 生殖補助医療市場：タイプ別

  • 人工授精
  • ドナーコンセプション
  • 受精卵卵管内移植法
  • 体外受精
  • 排卵誘発
  • 代理出産

第7章 生殖補助医療市場：診断別

  • 遺伝子検査
  • ホルモン検査
  • 子宮卵管造影検査
  • 画像検査
  • 卵巣予備能検査
  • 排卵検査薬

第8章 生殖補助医療市場：エンドユーザー別

  • クリニック
  • 婦人科センター
  • 病院
  • 体外受精センター

第9章 南北アメリカの生殖補助医療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の生殖補助医療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの生殖補助医療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Carl Zeiss AG
    • CCB Kitazato, LLC
    • CooperSurgical, Inc. Cooper Companies Inc.
    • Cryolab Ltd.
    • Esco Micro Pte. Ltd.Esco Lifesciences Group
    • Ferring B.V.
    • FUJIFILM Irvine Scientific, Inc.
    • Genea Limited
    • INVO Bioscience
    • Merck & Co., Inc.
    • Nidacon International AB
    • Planer PLC by Hamilton Thorne, Inc.
    • Rocket Medical plc by Roko AB
    • Thermo Fisher Scientific company
    • Vitrolife AB
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET DYNAMICS
  • FIGURE 7. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 10. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DONOR CONCEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION INDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 13. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HORMONE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IMAGING TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVARIAN RESERVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OVULATION TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GYNECOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILISATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 152. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET LICENSE & PRICING
目次
Product Code: MRR-436901065AA1

[194 Pages Report] The Assisted Reproductive Technology Market size was estimated at USD 25.12 billion in 2023 and expected to reach USD 29.52 billion in 2024, at a CAGR 17.57% to reach USD 78.04 billion by 2030.

Global Assisted Reproductive Technology Market

KEY MARKET STATISTICS
Base Year [2023] USD 25.12 billion
Estimated Year [2024] USD 29.52 billion
Forecast Year [2030] USD 78.04 billion
CAGR (%) 17.57%
Assisted Reproductive Technology Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Assisted Reproductive Technology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Assisted Reproductive Technology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Roko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Artificial Insemination
    • Donor Conception
    • Gamete Intrafallopian Transfer
    • In Vitro Fertilization
    • Ovulation Induction
    • Surrogacy
  • Diagnosis
    • Genetic Testing
    • Hormone Testing
    • Hysterosalpingography
    • Imaging Testing
    • Ovarian Reserve Testing
    • Ovulation Testing
  • End User
    • Clinics
    • Gynecology Centers
    • Hospitals
    • In Vitro Fertilisation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Assisted Reproductive Technology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Assisted Reproductive Technology Market?

3. What are the technology trends and regulatory frameworks in the Assisted Reproductive Technology Market?

4. What is the market share of the leading vendors in the Assisted Reproductive Technology Market?

5. Which modes and strategic moves are suitable for entering the Assisted Reproductive Technology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Assisted Reproductive Technology Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
      • 5.1.1.2. Rising healthcare expenditure across emerging nations
      • 5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
    • 5.1.2. Restraints
      • 5.1.2.1. High cost required for the procedure and lower success rate
    • 5.1.3. Opportunities
      • 5.1.3.1. Initiatives from government and public organizations to increase awareness
      • 5.1.3.2. Technological advancements to reduce the treatment complications
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of advanced infrastructure in developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Assisted Reproductive Technology Market, by Type

  • 6.1. Introduction
  • 6.2. Artificial Insemination
  • 6.3. Donor Conception
  • 6.4. Gamete Intrafallopian Transfer
  • 6.5. In Vitro Fertilization
  • 6.6. Ovulation Induction
  • 6.7. Surrogacy

7. Assisted Reproductive Technology Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. Genetic Testing
  • 7.3. Hormone Testing
  • 7.4. Hysterosalpingography
  • 7.5. Imaging Testing
  • 7.6. Ovarian Reserve Testing
  • 7.7. Ovulation Testing

8. Assisted Reproductive Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Gynecology Centers
  • 8.4. Hospitals
  • 8.5. In Vitro Fertilisation Centers

9. Americas Assisted Reproductive Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Assisted Reproductive Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Carl Zeiss AG
    • 13.1.2. CCB Kitazato, LLC
    • 13.1.3. CooperSurgical, Inc. Cooper Companies Inc.
    • 13.1.4. Cryolab Ltd.
    • 13.1.5. Esco Micro Pte. Ltd.Esco Lifesciences Group
    • 13.1.6. Ferring B.V.
    • 13.1.7. FUJIFILM Irvine Scientific, Inc.
    • 13.1.8. Genea Limited
    • 13.1.9. INVO Bioscience
    • 13.1.10. Merck & Co., Inc.
    • 13.1.11. Nidacon International AB
    • 13.1.12. Planer PLC by Hamilton Thorne, Inc.
    • 13.1.13. Rocket Medical plc by Roko AB
    • 13.1.14. Thermo Fisher Scientific company
    • 13.1.15. Vitrolife AB
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing